{"nct_id":"NCT01709513","title":"Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)","status":"COMPLETED","status_verified_date":"2020-06","start_date":"2012-09-30","start_date_type":"ACTUAL","primary_completion_date":"2014-05-31","primary_completion_date_type":"ACTUAL","completion_date":"2017-05-31","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["REGN"]}